Unraveling the Determinants of Protrusion Formation

Table 5

Effects of Rho-kinase/myosin inhibitors on the prevalence of factor 7 features^a.

Tukey grouping			Mean	Combination of agents
A			0.92	H1152p, ROCK inhibitor (20.2 μM)
A			0.79	H1152p (5.0 μM)
A	B		0.12	SPC16524, MLC kinase inhibitor (680 μM)
	B		0.03	Control (PMA + LPA)
	B	C	−0.19	SPC16524 (170 μM)
	B	C	−0.20	Blebbistatin, myosin ATPase inhibitor (0.2 μM)
	B	C	−0.37	Blebbistatin (0.8 μM)
		C	−0.85	Control (untreated)

^aMeans with the same letter are statistically indistinguishable at the level 𝑃<0.05.